SCHEMBL7976276

SCHEMBL7976276

Cc1c(C(=O)O)[nH]c2ncccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.46
ALDH1A1 P00352 3/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MCL1 Q07820 2/20 0.46
POLB P06746 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
HTT P42858 1/20 0.46
RECQL P46063 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
AURKA O14965 1/20 0.46
PARP1 P09874 1/20 0.46
FEN1 P39748 1/20 0.45
GPR35 Q9HC97 1/20 0.44
CAMKK2 Q96RR4 1/20 0.43
MAP2K1 Q02750 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7965829 0.85 MAP2K1 (0.54) KDM4EALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL16497523 0.83 AURKA (0.46) KDM4EALDH1A1L3MBTL1MAPTTSHR
SCHEMBL16497485 0.83 AURKA (0.46) KDM4EALDH1A1L3MBTL1MAPTTSHR
SCHEMBL16464368 0.82 ALDH1A1 (0.48) KDM4EALDH1A1MEN1KMT2APOLB
SCHEMBL4070897 0.81 AURKA (0.45) KDM4EALDH1A1L3MBTL1KMT2AMAPT
SCHEMBL29621825 0.81 AURKA (0.45) KDM4EALDH1A1L3MBTL1KMT2AMAPT
SCHEMBL16496875 0.81 AURKA (0.45) KDM4EALDH1A1L3MBTL1MAPTTSHR
SCHEMBL29621724 0.81 AURKA (0.45) KDM4EALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL7975743 0.81 AURKA (0.45) KDM4EALDH1A1L3MBTL1MAPTTSHR
SCHEMBL3004321 0.81 AURKA (0.45) KDM4EALDH1A1L3MBTL1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110312938-A1 Pyrrolopyridine Carboxylic Acid Derivatives IRONWOOD PHARMACEUTICALS, INC. (US) 2011-12-22 US claimed
WO-2024162746-A1 INDOLE COMPOUND DECOMPOSING IKZF2, AND USE THEREOF 한국화학연구원 2024-08-08 WO disclosed
US-20110312938-A1 Pyrrolopyridine Carboxylic Acid Derivatives IRONWOOD PHARMACEUTICALS, INC. (US) 2011-12-22 US disclosed
US-20110312938-A1 Pyrrolopyridine Carboxylic Acid Derivatives IRONWOOD PHARMACEUTICALS, INC. (US) 2011-12-22 US disclosed
US-20110312938-A1 Pyrrolopyridine Carboxylic Acid Derivatives IRONWOOD PHARMACEUTICALS, INC. (US) 2011-12-22 US disclosed
WO-2010005528-A2 PYRROLOPYRIDINE CARBOXYLIC ACID DERIVATIVES IRONWOOD PHARMACEUTICALS INCORPORATED (US) 2010-01-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312938-A1 Pyrrolopyridine Carboxylic Acid Derivatives SDHA, ALDH5A1, SDHB KDM4E 3282/4885ALDH1A1 50/4885L3MBTL1 4225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.